News
17h
News-Medical.Net on MSNGLP-1 weight-loss drugs are reshaping modern dating and intimacyGLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.
After interviewing dozens of people on weight loss drugs like Zepbound and Ozempic, my view of GLP-1s has completely changed ...
Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 receptor agonist. High-profile endorsements, including from Elon Musk, have ...
After the American Academy of Pediatrics recommended the use of certain GLP-1 weight loss drugs in January of 2023, the use ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Explore more
Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...
5d
MedPage Today on MSNGLP-1 Therapy Helps Amplify Bariatric Surgery Weight Loss, But Timing MattersIn 568 patients who underwent bariatric surgery, those who also used a GLP-1 receptor agonist during the preoperative and ...
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.
GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity ...
A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...
A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results